Toolkit/AAV-PHP.(S+eB)

AAV-PHP.(S+eB)

Also known as: AAV-PHP.(S + eB)

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

we generated AAV with mosaic capsid, AAV-PHP.(S + eB), by co-packaging the AAV with two engineered capsid variants: AAV-PHP.eB and AAV-PHP.S

Usefulness & Problems

No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.

Published Workflows

Objective: Design an AAV vector that can efficiently transduce both central and peripheral nervous system compartments while reducing off-target liver transduction.

Why it works: The workflow combines a CNS-tropic parent capsid and a PNS-tropic parent capsid into a mosaic vector, with the expectation that the resulting particles can capture both targeting behaviors while reducing off-target transduction.

mosaic capsid assembly by co-packaging two engineered capsid variantsco-packaging engineered AAV capsid variantssystemic in vivo administrationcomparative benchmarking against parental vectors

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A delivery strategy grouped with the mechanism branch because it determines how a system is instantiated and deployed in context.

Target processes

recombination

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Observations

successMouseapplication demomouse

Inferred from claim claim2 during normalization. Systemic administration of AAV-PHP.(S+eB) in adult mice mediates widespread CNS transgene expression comparable to AAV-PHP.eB while also achieving robust dorsal root ganglia neuron transduction similar to AAV-PHP.S. Derived from claim claim2. Quoted text: Systemic administration of AAV-PHP.(S + eB) in adult mice mediated widespread transgene expression throughout the CNS, comparable to AAV-PHP.eB, while simultaneously achieving robust transduction of dorsal root ganglia neurons, similar to AAV-PHP.S.

Source:

successMouseapplication demomouseliver

Inferred from claim claim3 during normalization. AAV-PHP.(S+eB) shows significantly reduced off-target liver transduction compared with both parental vectors. Derived from claim claim3. Quoted text: the mosaic vector demonstrated significantly reduced off-target transduction in the liver compared to both parental vectors, suggesting an improved safety

Source:

Supporting Sources

Ranked Claims

Claim 1comparative performancesupports2025Source 1needs review

Systemic administration of AAV-PHP.(S+eB) in adult mice mediates widespread CNS transgene expression comparable to AAV-PHP.eB while also achieving robust dorsal root ganglia neuron transduction similar to AAV-PHP.S.

Systemic administration of AAV-PHP.(S + eB) in adult mice mediated widespread transgene expression throughout the CNS, comparable to AAV-PHP.eB, while simultaneously achieving robust transduction of dorsal root ganglia neurons, similar to AAV-PHP.S.
Claim 2design principlesupports2025Source 1needs review

Mosaic capsid assembly is presented as a strategy for designing dual-tropic AAV vectors without increasing viral dose.

These results indicate that mosaic capsid assembly is a potent strategy for designing dual-tropic AAV vectors without increasing viral dose.
Claim 3engineering strategysupports2025Source 1needs review

AAV-PHP.(S+eB) is a mosaic AAV generated by co-packaging the engineered capsid variants AAV-PHP.eB and AAV-PHP.S.

we generated AAV with mosaic capsid, AAV-PHP.(S + eB), by co-packaging the AAV with two engineered capsid variants: AAV-PHP.eB and AAV-PHP.S
Claim 4safety related observationsupports2025Source 1needs review

AAV-PHP.(S+eB) shows significantly reduced off-target liver transduction compared with both parental vectors.

the mosaic vector demonstrated significantly reduced off-target transduction in the liver compared to both parental vectors, suggesting an improved safety

Approval Evidence

1 source4 linked approval claimsfirst-pass slug aav-php-s-eb
we generated AAV with mosaic capsid, AAV-PHP.(S + eB), by co-packaging the AAV with two engineered capsid variants: AAV-PHP.eB and AAV-PHP.S

Source:

comparative performancesupports

Systemic administration of AAV-PHP.(S+eB) in adult mice mediates widespread CNS transgene expression comparable to AAV-PHP.eB while also achieving robust dorsal root ganglia neuron transduction similar to AAV-PHP.S.

Systemic administration of AAV-PHP.(S + eB) in adult mice mediated widespread transgene expression throughout the CNS, comparable to AAV-PHP.eB, while simultaneously achieving robust transduction of dorsal root ganglia neurons, similar to AAV-PHP.S.

Source:

design principlesupports

Mosaic capsid assembly is presented as a strategy for designing dual-tropic AAV vectors without increasing viral dose.

These results indicate that mosaic capsid assembly is a potent strategy for designing dual-tropic AAV vectors without increasing viral dose.

Source:

engineering strategysupports

AAV-PHP.(S+eB) is a mosaic AAV generated by co-packaging the engineered capsid variants AAV-PHP.eB and AAV-PHP.S.

we generated AAV with mosaic capsid, AAV-PHP.(S + eB), by co-packaging the AAV with two engineered capsid variants: AAV-PHP.eB and AAV-PHP.S

Source:

safety related observationsupports

AAV-PHP.(S+eB) shows significantly reduced off-target liver transduction compared with both parental vectors.

the mosaic vector demonstrated significantly reduced off-target transduction in the liver compared to both parental vectors, suggesting an improved safety

Source:

Comparisons

No literature-backed comparison notes have been materialized for this record yet.

Ranked Citations

  1. 1.

    Extracted from this source document.